Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
Thyroid : Official Journal of the American Thyroid Association|January 20, 2022
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical TrialVatche Tchekmedyian, Lara Dunn, Eric Sherman, et al.The Journal of Experimental Medicine|February 24, 2025
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAsGnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, et al.The Lancet. Oncology|January 21, 2023
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trialEric J Sherman, Jonathan Harris, Keith C Bible, et al.Nature Biomedical Engineering|March 14, 2020
Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancersSusanne Kossatz, Giacomo Pirovano, Paula Demétrio De Souza França, et al.The Journal of Clinical Endocrinology and Metabolism|September 27, 2018
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersLara A Dunn, Eric J Sherman, Shrujal S Baxi, et al.Cancer Cell|April 16, 2015
AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomasMoshe Elkabets, Evangelos Pazarentzos, Dejan Juric, et al.JAMA Surgery|May 26, 2018
Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid NodulesKepal N Patel, Trevor E Angell, Joshua Babiarz, et al.Surgery|October 10, 2025
Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumorsAradhya Nigam, Michael A Mederos, Yagiz A Aksoy, et al.Advances in Therapy|June 4, 2020
Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative ReviewAndrés Coca-Pelaz, Jatin P Shah, Juan C Hernandez-Prera, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2021
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid CarcinomaBin Xu, Talia L Fuchs, Sara Ahmadi, et al.Pageof 14